CO 134444
Alternative Names: V 134444Latest Information Update: 29 Aug 2007
At a glance
- Originator Purdue Pharma
- Class Anxiolytics; Hypnosedatives
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 13 Feb 2006 No development reported - Preclinical for Insomnia in USA (unspecified route)
- 23 Dec 2002 This compound is still in active development
- 17 Jan 2000 Preclinical development for Insomnia in USA (unspecified route)